Mark Allan Goldstein, M.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Anorexia Nervosa | 13 | 2021 | 1286 | 0.880 |
Why?
|
| Bone Density | 12 | 2021 | 3469 | 0.380 |
Why?
|
| Amenorrhea | 4 | 2018 | 485 | 0.330 |
Why?
|
| Sex Education | 1 | 2008 | 93 | 0.320 |
Why?
|
| Contraceptives, Oral, Combined | 1 | 2008 | 113 | 0.310 |
Why?
|
| Immunization Schedule | 1 | 2009 | 221 | 0.310 |
Why?
|
| Contraceptives, Oral, Hormonal | 1 | 2008 | 188 | 0.300 |
Why?
|
| Pregnancy in Adolescence | 1 | 2008 | 157 | 0.290 |
Why?
|
| Papillomavirus Infections | 2 | 2009 | 1585 | 0.290 |
Why?
|
| Feeding Behavior | 2 | 2016 | 3187 | 0.280 |
Why?
|
| Adolescent Behavior | 6 | 2011 | 1150 | 0.280 |
Why?
|
| Bone and Bones | 5 | 2019 | 2575 | 0.280 |
Why?
|
| Vaginal Smears | 1 | 2009 | 511 | 0.270 |
Why?
|
| Papillomavirus Vaccines | 2 | 2009 | 489 | 0.260 |
Why?
|
| Estrogen Replacement Therapy | 3 | 2021 | 1202 | 0.260 |
Why?
|
| Uterine Cervical Dysplasia | 1 | 2009 | 385 | 0.260 |
Why?
|
| Contraception | 1 | 2008 | 356 | 0.250 |
Why?
|
| Ultrasonography, Interventional | 1 | 2013 | 1483 | 0.250 |
Why?
|
| Men | 1 | 2003 | 63 | 0.230 |
Why?
|
| Hip | 2 | 2014 | 257 | 0.210 |
Why?
|
| Adolescent Medicine | 1 | 2002 | 72 | 0.210 |
Why?
|
| Abdominal Pain | 1 | 2008 | 1059 | 0.200 |
Why?
|
| Kidney Diseases | 1 | 2013 | 2145 | 0.200 |
Why?
|
| Vaccination | 2 | 2009 | 3256 | 0.200 |
Why?
|
| Biopsy | 1 | 2013 | 6756 | 0.190 |
Why?
|
| Insulin-Like Growth Factor I | 4 | 2021 | 2014 | 0.180 |
Why?
|
| Puberty | 1 | 2003 | 489 | 0.180 |
Why?
|
| Vaccines | 1 | 2009 | 817 | 0.180 |
Why?
|
| Sexually Transmitted Diseases, Viral | 2 | 2009 | 40 | 0.170 |
Why?
|
| Athletes | 2 | 2018 | 1092 | 0.160 |
Why?
|
| Estradiol | 4 | 2021 | 2021 | 0.150 |
Why?
|
| Adolescent | 27 | 2021 | 85649 | 0.150 |
Why?
|
| Universities | 1 | 2002 | 953 | 0.140 |
Why?
|
| Menstruation | 2 | 2008 | 299 | 0.140 |
Why?
|
| Absorptiometry, Photon | 7 | 2019 | 1726 | 0.140 |
Why?
|
| Hepatitis B Vaccines | 1 | 1995 | 194 | 0.120 |
Why?
|
| Anorexia | 1 | 2014 | 159 | 0.120 |
Why?
|
| Estrogens | 1 | 2021 | 1562 | 0.120 |
Why?
|
| Risk-Taking | 3 | 2008 | 986 | 0.120 |
Why?
|
| Carcinoma, Squamous Cell | 1 | 2009 | 4029 | 0.110 |
Why?
|
| Adaptation, Psychological | 1 | 2003 | 2575 | 0.110 |
Why?
|
| Age Determination by Skeleton | 2 | 2013 | 129 | 0.110 |
Why?
|
| Refeeding Syndrome | 1 | 2011 | 14 | 0.100 |
Why?
|
| Attitude to Health | 2 | 2013 | 2051 | 0.100 |
Why?
|
| Hypernatremia | 1 | 2012 | 82 | 0.100 |
Why?
|
| Sports | 2 | 2008 | 686 | 0.100 |
Why?
|
| Female Athlete Triad Syndrome | 1 | 2011 | 55 | 0.100 |
Why?
|
| Urography | 1 | 2012 | 313 | 0.100 |
Why?
|
| Soccer | 1 | 2012 | 132 | 0.090 |
Why?
|
| Frostbite | 1 | 2009 | 24 | 0.090 |
Why?
|
| Hepatitis B | 1 | 1995 | 695 | 0.090 |
Why?
|
| Urothelium | 1 | 2012 | 277 | 0.090 |
Why?
|
| Rewarming | 1 | 2009 | 61 | 0.090 |
Why?
|
| Adolescent Development | 1 | 2013 | 277 | 0.090 |
Why?
|
| Bone Development | 1 | 2013 | 483 | 0.090 |
Why?
|
| Body Dysmorphic Disorders | 1 | 2013 | 229 | 0.090 |
Why?
|
| Human Growth Hormone | 3 | 2009 | 683 | 0.090 |
Why?
|
| Competitive Bidding | 1 | 2008 | 17 | 0.080 |
Why?
|
| Fecal Impaction | 1 | 2008 | 34 | 0.080 |
Why?
|
| Alcoholic Intoxication | 1 | 2009 | 188 | 0.080 |
Why?
|
| Fractures, Bone | 2 | 2018 | 1945 | 0.080 |
Why?
|
| Hypothermia | 1 | 2009 | 189 | 0.080 |
Why?
|
| Foot Injuries | 1 | 2009 | 148 | 0.080 |
Why?
|
| Creatinine | 1 | 2013 | 1916 | 0.070 |
Why?
|
| Adolescent Psychiatry | 1 | 2008 | 148 | 0.070 |
Why?
|
| Intrauterine Devices | 1 | 2008 | 122 | 0.070 |
Why?
|
| Diagnosis, Differential | 4 | 2012 | 12958 | 0.070 |
Why?
|
| Statistics, Nonparametric | 1 | 2013 | 2885 | 0.070 |
Why?
|
| Hand Injuries | 1 | 2009 | 242 | 0.070 |
Why?
|
| Bradycardia | 1 | 2008 | 305 | 0.070 |
Why?
|
| Blood Chemical Analysis | 1 | 2008 | 440 | 0.070 |
Why?
|
| Chi-Square Distribution | 1 | 2013 | 3510 | 0.070 |
Why?
|
| Hip Fractures | 1 | 2014 | 954 | 0.070 |
Why?
|
| Ghrelin | 1 | 2008 | 266 | 0.070 |
Why?
|
| Child Psychiatry | 1 | 2008 | 220 | 0.070 |
Why?
|
| Humans | 33 | 2021 | 742088 | 0.070 |
Why?
|
| Hypotension, Orthostatic | 1 | 2008 | 255 | 0.070 |
Why?
|
| Cervix Uteri | 1 | 2009 | 591 | 0.060 |
Why?
|
| Body Height | 2 | 2008 | 1574 | 0.060 |
Why?
|
| Sexual Partners | 1 | 2009 | 730 | 0.060 |
Why?
|
| Obesity | 2 | 2019 | 12705 | 0.060 |
Why?
|
| Finite Element Analysis | 2 | 2019 | 431 | 0.060 |
Why?
|
| Female | 23 | 2021 | 379592 | 0.060 |
Why?
|
| Death, Sudden, Cardiac | 1 | 2012 | 1541 | 0.060 |
Why?
|
| Fibroblast Growth Factors | 1 | 2009 | 879 | 0.060 |
Why?
|
| Drug Resistance | 1 | 2009 | 1608 | 0.060 |
Why?
|
| Leptin | 2 | 2009 | 1593 | 0.060 |
Why?
|
| Growth Disorders | 1 | 2008 | 643 | 0.060 |
Why?
|
| Overweight | 1 | 2014 | 2366 | 0.060 |
Why?
|
| Genital Diseases, Male | 1 | 2003 | 83 | 0.060 |
Why?
|
| Body Composition | 4 | 2019 | 2400 | 0.050 |
Why?
|
| Osteogenesis | 1 | 2009 | 1299 | 0.050 |
Why?
|
| Anxiety Disorders | 1 | 2013 | 2684 | 0.050 |
Why?
|
| Tomography, X-Ray Computed | 4 | 2019 | 20086 | 0.050 |
Why?
|
| Physician's Role | 1 | 2008 | 942 | 0.050 |
Why?
|
| Young Adult | 7 | 2021 | 56350 | 0.050 |
Why?
|
| Logistic Models | 2 | 2013 | 13403 | 0.050 |
Why?
|
| Teaching | 1 | 2008 | 1174 | 0.050 |
Why?
|
| Weight Gain | 2 | 2007 | 2282 | 0.050 |
Why?
|
| Thrombolytic Therapy | 1 | 2009 | 2161 | 0.050 |
Why?
|
| Predictive Value of Tests | 2 | 2013 | 15056 | 0.040 |
Why?
|
| Male | 8 | 2016 | 349538 | 0.040 |
Why?
|
| Urinary Bladder Neoplasms | 1 | 2012 | 2229 | 0.040 |
Why?
|
| Psychotherapy | 1 | 2008 | 1644 | 0.040 |
Why?
|
| Administration, Cutaneous | 1 | 2021 | 711 | 0.040 |
Why?
|
| Pediatrics | 2 | 2008 | 3462 | 0.040 |
Why?
|
| Adult | 9 | 2014 | 213712 | 0.040 |
Why?
|
| Orthomyxoviridae | 2 | 1970 | 156 | 0.040 |
Why?
|
| Catheterization | 1 | 1994 | 1468 | 0.040 |
Why?
|
| Patient Compliance | 1 | 2008 | 2680 | 0.040 |
Why?
|
| Kidney Transplantation | 1 | 2013 | 4246 | 0.040 |
Why?
|
| Body Weight | 1 | 2008 | 4664 | 0.040 |
Why?
|
| Bone Remodeling | 1 | 2021 | 575 | 0.040 |
Why?
|
| Sensitivity and Specificity | 2 | 2012 | 14720 | 0.040 |
Why?
|
| Clinical Competence | 1 | 2013 | 4681 | 0.040 |
Why?
|
| Weight Loss | 1 | 2008 | 2604 | 0.040 |
Why?
|
| Peptide YY | 2 | 2007 | 130 | 0.040 |
Why?
|
| Rural Health | 1 | 1978 | 305 | 0.030 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2008 | 10943 | 0.030 |
Why?
|
| Insulin | 2 | 2009 | 6575 | 0.030 |
Why?
|
| Curriculum | 1 | 2008 | 3589 | 0.030 |
Why?
|
| Child | 7 | 2011 | 77478 | 0.030 |
Why?
|
| Community Health Centers | 1 | 1978 | 428 | 0.030 |
Why?
|
| Cross-Sectional Studies | 5 | 2014 | 24913 | 0.030 |
Why?
|
| Prognosis | 3 | 2009 | 29010 | 0.030 |
Why?
|
| Chemical Phenomena | 1 | 2013 | 517 | 0.030 |
Why?
|
| Community Health Services | 1 | 1978 | 650 | 0.030 |
Why?
|
| Porosity | 1 | 2013 | 362 | 0.030 |
Why?
|
| Primary Health Care | 1 | 2008 | 4551 | 0.030 |
Why?
|
| Triiodobenzoic Acids | 1 | 2012 | 123 | 0.030 |
Why?
|
| Risk Assessment | 2 | 2014 | 23320 | 0.030 |
Why?
|
| Drug Therapy, Combination | 1 | 2021 | 6483 | 0.020 |
Why?
|
| Aged, 80 and over | 2 | 2013 | 57683 | 0.020 |
Why?
|
| Sex Hormone-Binding Globulin | 1 | 2013 | 548 | 0.020 |
Why?
|
| Hallux | 1 | 2009 | 39 | 0.020 |
Why?
|
| Culture Techniques | 1 | 1970 | 554 | 0.020 |
Why?
|
| Menstrual Cycle | 1 | 2013 | 551 | 0.020 |
Why?
|
| Diuretics | 1 | 2012 | 591 | 0.020 |
Why?
|
| Procollagen | 1 | 2009 | 185 | 0.020 |
Why?
|
| Risk Factors | 3 | 2009 | 72145 | 0.020 |
Why?
|
| Heterocyclic Compounds | 1 | 1970 | 249 | 0.020 |
Why?
|
| Mental Disorders | 1 | 2008 | 6587 | 0.020 |
Why?
|
| Pregnancy | 2 | 2008 | 29087 | 0.020 |
Why?
|
| Formaldehyde | 1 | 1970 | 353 | 0.020 |
Why?
|
| Femur | 1 | 2014 | 1297 | 0.020 |
Why?
|
| Sexual Development | 1 | 2008 | 34 | 0.020 |
Why?
|
| Acylation | 1 | 2008 | 107 | 0.020 |
Why?
|
| Internship and Residency | 1 | 2008 | 5774 | 0.020 |
Why?
|
| Retrospective Studies | 2 | 2014 | 77098 | 0.020 |
Why?
|
| Mercury | 1 | 1970 | 285 | 0.020 |
Why?
|
| Lactones | 1 | 1970 | 329 | 0.020 |
Why?
|
| Double-Blind Method | 1 | 2021 | 12017 | 0.020 |
Why?
|
| Gonadotropins | 1 | 2008 | 241 | 0.020 |
Why?
|
| Health | 1 | 2009 | 390 | 0.020 |
Why?
|
| Diagnostic and Statistical Manual of Mental Disorders | 1 | 2013 | 1953 | 0.020 |
Why?
|
| Collagen Type I | 1 | 2009 | 592 | 0.020 |
Why?
|
| Organometallic Compounds | 1 | 1970 | 665 | 0.020 |
Why?
|
| Reference Values | 1 | 2013 | 4982 | 0.020 |
Why?
|
| Anti-Bacterial Agents | 1 | 1994 | 7153 | 0.020 |
Why?
|
| Area Under Curve | 1 | 2009 | 1653 | 0.020 |
Why?
|
| Exercise Test | 1 | 2013 | 2075 | 0.020 |
Why?
|
| Longitudinal Studies | 1 | 2021 | 13921 | 0.020 |
Why?
|
| Apolipoproteins B | 1 | 2006 | 373 | 0.020 |
Why?
|
| Radiographic Image Interpretation, Computer-Assisted | 1 | 2012 | 1183 | 0.020 |
Why?
|
| Ultraviolet Rays | 1 | 1970 | 1059 | 0.020 |
Why?
|
| Clavulanic Acids | 1 | 1994 | 11 | 0.020 |
Why?
|
| Hand | 1 | 2009 | 882 | 0.020 |
Why?
|
| Prospective Studies | 4 | 2012 | 53187 | 0.010 |
Why?
|
| Angiography | 1 | 2009 | 1636 | 0.010 |
Why?
|
| Gonadal Steroid Hormones | 1 | 2008 | 711 | 0.010 |
Why?
|
| Blood Glucose | 2 | 2009 | 6249 | 0.010 |
Why?
|
| Aged | 2 | 2013 | 162944 | 0.010 |
Why?
|
| Health Policy | 1 | 1995 | 2657 | 0.010 |
Why?
|
| Body Mass Index | 2 | 2013 | 12695 | 0.010 |
Why?
|
| Amoxicillin | 1 | 1994 | 170 | 0.010 |
Why?
|
| Testosterone | 1 | 2013 | 2401 | 0.010 |
Why?
|
| Heart Arrest | 1 | 2012 | 1469 | 0.010 |
Why?
|
| Middle Aged | 2 | 2013 | 213127 | 0.010 |
Why?
|
| Ciprofloxacin | 1 | 1994 | 314 | 0.010 |
Why?
|
| Prevalence | 1 | 2018 | 15194 | 0.010 |
Why?
|
| Case-Control Studies | 2 | 2009 | 21719 | 0.010 |
Why?
|
| Adiponectin | 1 | 2007 | 1099 | 0.010 |
Why?
|
| Cardiovascular Diseases | 1 | 2006 | 15108 | 0.010 |
Why?
|
| Risk | 1 | 2013 | 9679 | 0.010 |
Why?
|
| Vancomycin | 1 | 1994 | 500 | 0.010 |
Why?
|
| Boston | 1 | 2013 | 9305 | 0.010 |
Why?
|
| Imaging, Three-Dimensional | 1 | 2013 | 4029 | 0.010 |
Why?
|
| Recombinant Proteins | 1 | 2009 | 6608 | 0.010 |
Why?
|
| Hydrocortisone | 1 | 2007 | 1825 | 0.010 |
Why?
|
| Triglycerides | 1 | 2006 | 2450 | 0.010 |
Why?
|
| Contrast Media | 1 | 2012 | 5295 | 0.010 |
Why?
|
| Drug Combinations | 1 | 1994 | 1961 | 0.010 |
Why?
|
| New Mexico | 1 | 1978 | 86 | 0.010 |
Why?
|
| Chick Embryo | 2 | 1970 | 981 | 0.010 |
Why?
|
| Cholesterol | 1 | 2006 | 2895 | 0.010 |
Why?
|
| Regression Analysis | 1 | 2007 | 6452 | 0.010 |
Why?
|
| Peptides | 1 | 2009 | 4392 | 0.010 |
Why?
|
| Interleukin-6 | 1 | 2006 | 3199 | 0.010 |
Why?
|
| Peptide Fragments | 1 | 2009 | 5095 | 0.010 |
Why?
|
| Pilot Projects | 1 | 2008 | 8297 | 0.010 |
Why?
|
| C-Reactive Protein | 1 | 2006 | 3766 | 0.010 |
Why?
|
| Treatment Outcome | 1 | 2021 | 62966 | 0.010 |
Why?
|
| United States | 2 | 2008 | 69693 | 0.010 |
Why?
|
| Insulin Resistance | 1 | 2007 | 3861 | 0.010 |
Why?
|
| Hemadsorption | 1 | 1970 | 7 | 0.010 |
Why?
|
| Hemagglutination, Viral | 1 | 1970 | 12 | 0.010 |
Why?
|
| Radiation Effects | 1 | 1970 | 68 | 0.010 |
Why?
|
| Agglutination | 1 | 1970 | 43 | 0.010 |
Why?
|
| Hemagglutination Inhibition Tests | 1 | 1970 | 77 | 0.010 |
Why?
|
| Cytopathogenic Effect, Viral | 1 | 1970 | 156 | 0.010 |
Why?
|
| Agglutination Tests | 1 | 1970 | 41 | 0.010 |
Why?
|
| Hemagglutinins, Viral | 1 | 1970 | 67 | 0.010 |
Why?
|
| Antigen-Antibody Reactions | 1 | 1970 | 363 | 0.010 |
Why?
|
| Haplorhini | 1 | 1970 | 551 | 0.010 |
Why?
|
| Culture Media | 1 | 1970 | 902 | 0.000 |
Why?
|
| Cricetinae | 1 | 1970 | 2471 | 0.000 |
Why?
|
| Follow-Up Studies | 1 | 2007 | 39004 | 0.000 |
Why?
|
| Dogs | 1 | 1970 | 3910 | 0.000 |
Why?
|
| Rabbits | 1 | 1970 | 4886 | 0.000 |
Why?
|
| Antiviral Agents | 1 | 1970 | 2978 | 0.000 |
Why?
|
| Cell Line | 1 | 1970 | 15994 | 0.000 |
Why?
|
| Kidney | 1 | 1970 | 7167 | 0.000 |
Why?
|
| Animals | 2 | 1970 | 168561 | 0.000 |
Why?
|